2 unknown, 1 not yet recruiting, 1 suspended. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 2, Not yet recruiting 1, Suspended 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow CM082: new trials by email Literature Review of CM082 trials Research Report on CM082
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients Vorolanib, cadonilimab - Kidney Cancer, RCC | Phase 1 / Phase 2 | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 37 | 2024-08-31 | 2024-08-29 |
| CM082 in Patients With Myopic Choroidal Neovascularization (CNV) CM082 - Myopic Choroidal Neovascularisation | Phase 1 | Suspended | AnewPharma | 96 | 2019-12-18 | 2021-03-10 |
| Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors CM082 - Advanced Malignant Solid Tumors | Phase 1 | Unknown | AnewPharma | 19 | 2019-02-26 | 2022-11-14 |
| Study of the Combination of CM082 With Everolimus in Patients With mRCC CM082, Everolimus - Renal Cell Carcinoma Recurrent | Phase 1 | Unknown | AnewPharma | 18 | 2015-09-01 | 2018-01-10 |
Carcinoma, Renal Cell (1) · Kidney Neoplasms (1)
AnewPharma (3) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)
China (3)
Jin Li, M.D (1) · Jun Guo, M.D (1) · Xinan Sheng, M.D (1) · Youxin Chen (1)